Gushengtang TCM plans to generate SGD 1 billion in revenue over the next 7 years through clinic expansion, AI-driven clinical systems, and HSA-certified products.<\/p>\n
Publicly listed Traditional Chinese Medicine (TCM) group Gushengtang TCM<\/a> is expanding into Singapore with bold plans to establish 30 TCM clinics by 2026 and roll out its proprietary \u2018Master TCM AI\u2019 system across the island.\u00a0<\/p>\n Gushengtang will focus on three areas of regional growth: expanding its clinic network, advancing its AI-powered clinical system, and obtaining international certification for its medical products. This aligns with the company\u2019s broader goal of integrating traditional and modern medicine. The initiative follows a strategic investment agreement with August Global Partners (AGP)<\/a>, a Singapore-based fund management company focused on healthcare, advanced manufacturing, and AI-powered health technologies. Together, the collaboration aims to achieve SGD 1 billion in revenue in Singapore over the next seven years.<\/p>\n Gushengtang introduces Master TCM AI system<\/b><\/p>\n Gushengtang, recognised as one of the fastest-growing professional TCM groups in Asia, aims to open 30 clinics across Singapore by the end of 2026, supported by local partnerships and the introduction of its \u2018Master TCM AI\u2019 system. Officially launched at GovWare 2025, the system combines three decades of clinical experience with artificial intelligence to help physicians deliver more precise, data-backed TCM care.<\/p>\n Built from the clinical insights of 10 expert physicians, the system spans eight major specialities: oncology, dermatology, gastroenterology, otolaryngology, andrology, psychology and sleep medicine, classical formula medicine, and orthopaedics.<\/p>\n \u2018Master TCM AI\u2019 supports doctors across five key stages of care: symptom collection, medical record generation, syndrome differentiation, prescription formulation, and post-consultation follow-up.<\/p>\n For physicians, the platform serves as a clinical co-pilot, offering evidence-informed recommendations and supporting case analysis. For patients, it enhances continuity of care by tracking treatment outcomes and offering lifestyle recommendations aligned with TCM principles.<\/p>\n Gushengtang partners 1doc<\/b><\/p>\n